Tibet AIM Pharm. Inc. (SHE:002826)

Tibet AIM Pharm. Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	625.86	649.72	666.8	856.53	724.36	602.15
Other Revenue	2.16	2.16	0.23	0.21	1.1	0.47
Revenue	628.02	651.88	667.04	856.73	725.46	602.62
Revenue Growth (YoY)	-2.11%	-2.27%	-22.14%	18.09%	20.38%	8.92%
Cost of Revenue	123.84	205.54	325.59	480.7	464.96	386.02
Gross Profit	504.19	446.34	341.45	376.03	260.5	216.6
Selling, General & Admin	420.48	390.65	298.35	317.92	218.48	178.24
Research & Development	13.28	15.48	13.71	13.35	11.39	6.85
Other Operating Expenses	6.9	12.27	11.5	-8.2	-9.81	-7.44
Operating Expenses	438.69	419.08	316.54	329.71	218.93	177.4
Operating Income	65.5	27.26	24.91	46.32	41.58	39.2
Interest Expense	-0.99	-0.45	-1.18	-0.81	-0.84	-1.62
Interest & Investment Income	5.79	5.2	5.06	3.93	2.92	1.55
Currency Exchange Gain (Loss)	0	0	0	0	-0	-0
Other Non Operating Income (Expenses)	0.31	-0.3	1.06	3.23	2.8	-1.92
EBT Excluding Unusual Items	70.6	31.71	29.85	52.68	46.46	37.22
Impairment of Goodwill	-	-	-19.8	-	-	-
Gain (Loss) on Sale of Assets	-0.48	-0.04	0.03	-	0.03	-0.12
Asset Writedown	-0.21	-0.2	-0.13	-0.08	-0.08	-0.05
Other Unusual Items	42.05	28.91	13.65	4.1	3.6	10.29
Pretax Income	111.96	60.38	23.6	56.7	50.01	47.35
Income Tax Expense	25.35	12.92	7.87	10.59	6.54	6.26
Earnings From Continuing Operations	86.6	47.46	15.73	46.12	43.47	41.09
Minority Interest in Earnings	-0.73	-1.53	-0.34	-1.98	-1	-
Net Income	85.87	45.93	15.39	44.14	42.48	41.09
Net Income to Common	85.87	45.93	15.39	44.14	42.48	41.09
Net Income Growth	157.74%	198.50%	-65.14%	3.91%	3.37%	10.08%
Shares Outstanding (Basic)	181	184	192	192	193	187
Shares Outstanding (Diluted)	181	184	192	192	193	187
Shares Change (YoY)	-8.40%	-4.48%	0.23%	-0.61%	3.37%	0.07%
EPS (Basic)	0.48	0.25	0.08	0.23	0.22	0.22
EPS (Diluted)	0.48	0.25	0.08	0.23	0.22	0.22
EPS Growth	181.39%	212.50%	-65.22%	4.54%	-	10.00%
Free Cash Flow	139.01	99.33	163.7	65.26	84.33	63.31
Free Cash Flow Per Share	0.77	0.54	0.85	0.34	0.44	0.34
Dividend Per Share	0.100	0.100	0.030	0.100	0.100	0.080
Dividend Growth	233.33%	233.33%	-70.00%	-	25.00%	100.00%
Gross Margin	80.28%	68.47%	51.19%	43.89%	35.91%	35.94%
Operating Margin	10.43%	4.18%	3.73%	5.41%	5.73%	6.51%
Profit Margin	13.67%	7.05%	2.31%	5.15%	5.85%	6.82%
Free Cash Flow Margin	22.13%	15.24%	24.54%	7.62%	11.62%	10.51%
EBITDA	85.12	48.82	49.05	69.02	65.24	55.95
EBITDA Margin	13.55%	7.49%	7.35%	8.06%	8.99%	9.28%
D&A For EBITDA	19.62	21.55	24.14	22.7	23.66	16.74
EBIT	65.5	27.26	24.91	46.32	41.58	39.2
EBIT Margin	10.43%	4.18%	3.73%	5.41%	5.73%	6.51%
Effective Tax Rate	22.65%	21.39%	33.37%	18.67%	13.08%	13.21%
Revenue as Reported	628.02	651.88	667.04	856.73	725.46	602.62

Source: S&P Global Market Intelligence. Standard template. Financial Sources.